 B-ALL patients can be included in the study up to five years from diagnosis. After completing the enrollment of the cross-sectional study, PI will be queried on RemissionRelapse status of patients. Above is the minimum number of patients to be enrolled. Up to 12 patients at relapse and 31 patents at remission can be enrolled. 